The IGF2 gene, which encodes a growth factor, is subject to genomic imprinting. The frequently observed loss of IGF2 imprinting in a variety of tumors has been suggested to contribute to neoplasia. Since these reports have not documented the imprinting status of IGF2 at the cellular level, it cannot be excluded that the imprinting status might vary within the tumor. The possibility that loss of IGF2 imprinting in neoplastic cells re¯ects random imprinting patterns, was therefore addressed. We show here that individual cell populations of the JEG-3 choriocarcinoma cell line display heterogenous imprinting patterns of both IGF2 and H19. In addition, a lack of correlation between IGF2 and H19 imprinting status suggests that any regional parental imprint has been functionally lost. This notion is reinforced by the observation that JEG-3 cell subclones display a range of promoter-speci®c IGF2 allele usage. Moreover, we observed that the imprinting status of H19 and IGF2 were dierentially modulated in JEG-3-derived tumors generated in nude mice. The results suggest that allele-speci®c expression of IGF2 operates in the absence of a parental imprint. Finally, our observations urge caution with respect to the general interpretation of biallelic expression as`loss of imprinting'.
Introduction
A subset of autosomal genes display a parent of origin dependent expression pattern. This phenomenon, which is termed genomic imprinting, involves assymetrical activation or inactivation of parental alleles, presumably re¯ecting the presence and/or absence of gametric implants (Ohlsson et al., 1995) . One of the cornerstones of genomic imprinting research has been the cluster of imprinted loci at the p15.5 region of human chromosome 11 (Mannens and Wilde, 1997) . The current list of members of this cluster includes the IGF2 and H19 genes which are expressed preferentially from the paternal and the maternal alleles, respectively (Ohlsson et al., 1995) . Whereas IGF2 produces a growth factor in both mouse and man (Stewart and Rotwein, 1996) , the function of H19 is enigmatic. In the mouse, sequences¯anking H19 control the activity of Igf2 in cis while the structural gene has no documented function in trans (Brannan et al., 1990; Leighton et al., 1995) .
By analogy to the mouse, it is often assumed that human H19 controls the activity of IGF2 in cis. Accordingly, the silencing of the H19 gene in some tumors, such as Wilms' tumors, has been linked with biallelic expression of IGF2 (Feinberg et al., 1994; Tycko et al., 1994) . This correlation is compounded, however, by several observations; Firstly, H19 is biallelically expressed in a subpopulation of trophoblasts which preferentially express IGF2 from one of the parental alleles (Adam et al., 1996) . Secondly, the biallelic expression of IGF2 in Wilms' tumors can be heterogenous such that either parental allele can be expressed monoallellically in dierent tumor cell subpopulations, as resolved by allele-speci®c in situ hybridisation analysis (Cui et al., in preparation) . This result suggests that any regional link between IGF2 and H19 is likely to be lost during tumorigenesis. Thirdly, the phenomenon of allele-speci®c processing, which produces novel splice variants of IGF2, shows that IGF2 can be biallelically expressed in the normal context (Cui et al., in preparation) .
To penetrate this issue in more detail, we adopted a strategy to examine individual populations of tumor cells. We chose the JEG-3 choriocarcinoma cell line for a number of reasons. Firstly, the H19 and IGF2 imprinting status appear to be uncoupled in extravillous cytotrophoblasts (Adam et al., 1996) , the normal counterpart of the JEG-3 cells. Secondly, choriocarcinomas have been included in the list of tumors that display loss of IGF2 imprinting (Hashimoto et al., 1995) . Thirdly, both IGF2 and H19 genes are active in the JEG-3 cells when propagated in vitro (Rachmilewitz et al., 1995) . To this end, we have examined 64 subclones of the JEG-3 choriocarcinoma cell line. The results show that the imprinting patterns of IGF2 and H19 are independently maintained both in vitro and in vivo. Moreover, the JEG-3 cell subclones display a range of promoter-speci®c imprinting status of IGF2. We conclude that the parental imprints governing the regional-speci®c imprinting patterns of IGF2 and H19 have been functionally lost during tumorigenesis and/or during in vitro propagation of cells. The results are compatible with the notion that a somatic form of allele-speci®c expression mechanism comes into play in the absence of a regional, parent of origin-speci®c control.
Results

Hypervariable imprinting status of IGF2 in individual JEG-3 cell populations
To examine the status of IGF2 and H19 imprinting an individual cell populations of neoplastic cells, we adopted the stategy of subcloning the choriocarcinoma cell line, JEG-3. The tendency of JEG-3 cells to aggregate during in vitro propagation precluded non-selectable cloning procedures, such as soft agar approaches. Instead, clones were generated by transfecting the pSV2neo plasmid into the JEG-3 cell line. Following neomycin selection, isolation and expansion of subclones for 4 ± 5 passages, we initally examined the imprinting status of IGF2 by the direct RNase protection analysis method, exploiting the (C-A)n repeat polymorphism within exon nine (Figure 1 ). Figure  2a shows that for a subset of the clones, the IGF2 imprinting status is heterogeneous such that subclones preferentially express either of the parental alleles. This approach did not readily allow a quantitative estimation, however, which lead us to examine the IGF2 imprinting status using an RT ± PCR analysis of the ApaI polymorphism within exon nine (Ogawa et al., 1993) . Using 32 P-labeled primers we could reproducibly quantitate the relative allele usage. Figure 2b shows the pattern of IGF2 allele usage for a subset of the JEG-3 clones. Except for nine of the subclones (which display allele-speci®c splicing of IGF2 mRNAs; Cui et al., in preparation), both approaches gave the same qualitative result with respect to IGF2 imprinting status. The relative levels of allele-speci®c expression were determined for each of the 64 cell clones, as represented graphically in Figure 2c . The IGF2 imprinting status is heterogeneous, therefore, when assessing the over-all imprinting status in 64 dierent JEG-3 cell subclones. We conclude that IGF2 can be monoallelically expressed from opposite parental alleles in individual clones of a choriocarcinoma cell line, even though the bulk of the cell clones expresses IGF2 biallelically.
Lack of coordination of imprinting status at the promoter level
Given that the four known promoters of IGF2 can contribute dierentially to the over-all allele-speci®c usage (Ekstrom et al., 1995) , we further examined four randomly chosen clones. To be able to quantitatively assess the promoter-speci®c allele usage, we adapted previously published protcols. To this end, cDNAs were ampli®ed such that the 5'-ends were derived from either exon 1,4,5 or 6, which were speci®c for promoters 1,2,3 and 4, respectively, as has been described (ErkstroÈ m et al., 1995) . Next, the cDNAs were subjected to an allele-speci®c Southern hybridization analysis (Adam et al., 1996) . Figure 3a shows that the speci®c oligo probes can discriminate between the cutting and non-cutting alleles. We could document, therefore, that the promoter-speci®c allele-usage diers amongst the JEG-3 clones. The promoter four of the 4 : 31 subclone, for example, directs transcription from both parental alleles, whereas promoters two and three direct transcription from preferentially one of the parental alleles. To verify that this approach produces quantitatively reliable data, exon 6-speci®c cDNAs were ampli®ed from tissue specimens which were homozygous for either the ApaI-cutting and non- (a) shows a subset of IGF2 allele usage in 19 dierent subclones, as determined by the direct method, based on RNase protection analysis . This approach exploits sequence polymorphisms in a (C-A)n repeat located in exon nine of the IGF2 gene. The fully protected band and the fragmented band patterns depict allelic variants of the IGF2 transcripts. (b) shows the IGF2 allele usage of the same set of clones, as determined by the indirect, PCR-based method (Ogawa et al., 1993) . Following reverse transcription, the cDNA is subjected to a PCR analysis using primers¯anking a polymorphic ApaI site. The allelic variants of the IGF2 transcripts can be visualized by digesting the resulting PCR product with ApaI. For controls of PCR reaction, see Figure 5 . (c) shows a summary of RT ± PCR analyses, which were quantitated in a Fuji phosphorimager. The Y-axis shows the relative proportion of allele usage of IGF2 for each of the 64 clones analysed cutting alleles. The cDNAs were mixed in appropriate ratios and subjected to allele-speci®c Southern blot hybridization analysis. Figure 3b shows that the expected signal intensity of each of the mixes, parallelled the allelic ratio of cDNAs.
Lack of coordination of IGF2 and H19 imprinting status
It is commonly assumed that IGF2 and H19 expression patterns are regionally controlled during normal development and that the silencing of H19 has an eect in cis on the IGF2 imprinting status in human tumors (Tycko, 1994; Feinberg et al., 1994) . Since allele-speci®c in situ hybridization analyses imply that the IGF2 imprinting patterns are independent of the H19 gene activity in normal (Adam et al., 1996) and uniparental (Adam et al., in preparation) trophoblasts, we wanted to examine this issue further. Figure 4a shows the H19 imprinting status for each clone as assessed by RT ± PCR analysis of the AluI polymorphic site within exon 5 (Hashimoto et al., 1995) . In contrast to the IGF2 imprinting status, the H19 allele usage was skewed with a preference towards to the AluI non-cutting allele, although individual clones to display preferential expression from the AluI-cutting allele (Figure 4b ). When combining the H19 and IGF2 imprinting status studies in a 2D plot, a non-random pattern is apparent ( Figure 4c) . By comparing the RT ± PCR data clone by clone, it is evident that the H19 allele usage is generally skewed in the cell clones which express IGF2 biallelically. Moreover, the IGF2 and H19 alleles can be found silenced or activated in random patterns in a subset of the cell clones. It appears, therefore, that the allele usage of the IGF2 and H19 genes are independent from each other in these cells.
In vivo modi®cation of H19 but not IGF2 imprinting status
Since it could be argued that the IGF2 and H19 imprinting status could be aected during in vitro (a) shows H19 allele usage in a subset of 18 dierent subclones, as determined by RT ± PCR analysis over a diagnostic AluI polymorphic site (Hashimoto et al., 1995) . The 32 P-labeled primers were used to amplify cDNAs which were subsequently restricted by AluI (see legend of Figure 2 for the rationale of RT ± PCR analysis). (b) shows a summary of RT ± PCR data, which was quantitated in a Fuji phosphorimager. The Y-axis shows the relative proportion of allele usage of H19 for each of the 64 clones analysed. (c) shows a comparison of the imprinting status of IGF2 and H19 for each of the JEG-3 subclones. The relative frequency of H19 and IGF2 allele usage (allele A over allele A+B) is indicated on the Y-and X-axis, respectively maintenance, we examined the imprinting status for IGF2 and H19 in clones expanded both in vitro and in vivo. Four randomly chosen clones were injected into nude mice to generate choriocarcinoma tumors. Figure  5a and b show that the imprinting status of IGF2 in these tumors, as determined by RT ± PCR, was similar or indentical to the in vitro propagated subclones. In contrast, the H19 imprinting status diered considerably, in some instances, between subclones grown in vivo and in vitro (Figure 5c and d) . We conclude that the imprinting status of H19 can be modulated independently of IGF2 during in vivo growth conditions.
The in vivo propagation of JEG-3 subclones was accompanied by signi®cant changes in the levels of both IGF2 and H19-derived transcripts. Figure 6 shows that irrespective of the initial H19 and IGF2 expression levels in the in vitro maintained cells, the corresponding tumors display equally high levels of cytoplasmic transcripts of the IGF2 and H19 genes. One possible conclusion of this observation is that these genes are upregulated during in vivo propagation. If so, in vivo growth in nude mice would not re¯ect a selection of H19-positive JEG-3 cells during tumor formation, as had been suggested (Rachmilewitz et al., 1995) . In fact, despite dierent levels of H19 gene expression during in vitro maintenance, we have been unable to document a persistent dierence in the tumorigenicity of the four randomly chosen cell clones. We also conclude that the expression levels of IGF2 can be signi®cantly modulated without aecting the allele-speci®c expression patterns.
Discussion
Mouse genetic studies have provided evidence for a regional control of Igf2/H19 imprinting patterns (Leighton et al., 1995) . The analogy to the mouse situation and the demonstration that a domain including the human IGF2 and H19 genes is asynchronously replicated (Kitsberg et al., 1993) , would seem to suggest that the H19/IGF2 imprinting status is also regionally controlled in humans. Since loss of H19 expression has been suggested to result in loss of IGF2 imprinting, the implication is that the regional control is stably maintained and that this can contribute to neoplasia (Feinberg et al., 1994; Tycko, 1994) .
Our results show that individual cell populations of the JEG-3 choriocarcinoma cell line display disparate imprinting patterns for both IGF2 and H19. The variability in the predominantly expressed allele for IGF2 and H19 among the clones examined was puzzling. If the imprinting status of these cells is platic in culture, then a transition of the transcriptional activity from allele A to allele B may occur (or vice versa), in which case the reduction of the cell number and expansion during cell passaging might serve to`®x' cells of this type in a given population. These clones gave the same pattern of allele usage over an estimated 10 ± 15 cell divisions, however (not shown), implying that the imprint is stable over shorter periods at least. This suggests that the original JEG-3 cells may have been oligoclonal in origin, or that switching events occur during the in vitro life of these cells, but over longer periods. A precedent for a switch in allele usage for H19 has been documented in the cerebellum of one patient (Zhang et al., 1993 ; see also Douc-Rasy et al., 1996) . It should also be noted that the allelic usage of H19 can vary within a lineage in the normal placenta (Adam et al., 1996) . The existence of a cellular mosaicism with regard to (promoter-speci®c) allele usage in an established human cancer cell line urges caution in interpreting biallelic expression as a loss of imprinting.
It would seem from our data that allele usage for each of the IGF2 promoters can be controlled independently in JEG-3 cells and does not always correlate with the H19 allele being predominantly used. This is in keeping with the apparently uncoupled functional imprinting status between IGF2 and H19 in human trophectodermal cell derivatives as revealed by allele-speci®c in situ hybridization (Adam et al., 1996) . These observations are dicult to reconcile with any simple model for coordinate control of H19 and IGF2 allele usage. On the other hand, the IGF2 P2-P4 promoters are all expressed from the paternal allele in a coordinate manner during prenatal human development, except in the choroid plexus (EkstroÈ m et al., 1995) . From a transcriptional p[oint of view, it may not be essential whether the four dierent IGF2 promoters direct transcription of a single locus or of four juxtaposed loci. It is particularly striking, therefore, that the promoter-speci®c IGF2 allele usage appears to be uncoupled in a random manner in the JEG-3 cell line. It is reasonable to assume that the allele`switching' that can be observed in the JEG-3 cell line results from the combined activity of each of the promoters. Whether the promoters direct transcription from one or the other parental allele appears to be a stochastic process in the JEG-3 cells. Similar results have been observed in Wilms' tumours expressing IGF2 biallelically (Hengmi Cui et al., in preparation). We suggest, therefore, that the non-coordinated and random functional imprinting status of IGF2 in JEG-3 cells may be the result of the loss of a higher order regulation of chromosomal domains. It is interesting to note that azacytidine treatment of JEG-3 cells generates monoallelic expression of both H19 and IGF2 (Barletta et al., 1997) , which suggests that a higher order control of imprinting status can be restored by inhibiting CpG methylation.
We have also documented here that the imprinting status of H19 (but not of IGF2), can be modi®ed in the in vivo context. We also note that the signi®cant increase in IGF2 gene activity during in vivo growth does not change the allele-speci®c expression patterns. Again, the notion that monoallelic expression of IGF2 and H19 can be maintained without any regional control in individual cell populations of a tumorigenic cell line, is reinforced. Our data emphasise, therefore, that an unstable epigenotype can generate chaos in the imprinting status of a tumor cell line. It is interesting in this context that human trophoblasts of complete hydatidiform moles, which lack the maternal genome, randomly activate or inactivate IGF2 and H19 (Adam et al., in preparation) . It cannot be ruled out, therefore, that our observations are speci®c for the trophoblastic lineage. It is known that the mechanism of Xinactivation, for example, diers between the soma and extra-embryonic cells (Lyon, 1995) . On the other hand, we have also observed that the allele usage of IGF2 is heterogenous in Wilms' tumors (Cui et al., in preparation). It is possible, therefore, that the implications here, of regional-speci®c loss of stability of the tumor epigenotype, are of a more general signi®cance.
The hypervariable imprinting status of IGF2 is incompatible with the presence of functional parental imprints in the JEG-3 cell populations. This deduction suggests that the parental imprint(s) is not necessary for monoallelic expression patterns of IGF2 and H19. Indeed, it is formally possible that a somatic type of IGF2 inactivation is part of a mechanism that manifests genomic imprinting. In this scenario, the parental imprint would not dictate inactivation per se but provide a regional cue, for example with respect to the assymmetry of the inactivation process. This possibility remains speculative, however, since it cannot be rule out that a somatic type of imprinting is a more general feature of tumor cells, involving normally non-imprinted loci. In summary, we provide evidence here that the parental imprint is either absent or not recognized in tumor cells grown both in vivo and in vitro. If the functional imprinting status of IGF2 and H19 is coordinated in the normal context, it has been lost in neoplastic trophoblasts. We submit that during neoplasia, parent of origin speci®c cues can be functionally lost to generate an instability in the regional control of clusters of imprinted genes.
Materials and methods
Cell samples and preparation of nucleic acids
The JEG-3 choriocarcinoma cell line was maintained as has been described (Franklin et al., 1991) . Subclones of the JEG-3 cell line were generated by transfecting a pSV2neo plasmid followed by neomycin selection as has been described (Franklin et al., 1991) . Neomycin-resistant clones were isolated and expanded for 4 ± 5 passages before analysis. Choriocarcinoma tumors were generated by subcutaneous injection of 10 6 cells into nude mice (NMRI strain; BomMice). The tumors analysed in this report were removed 4 ± 5 weeks following injection. Total cellular RNA and DNA was extracted as has been described (Adam et al., 1996) .
Genotype
All of the subclones were genotypes with respect to the presence of both parental IGF2 alleles, using the polymorphic (C-A)n repeat . In no case could we document any loss of heterozygosity. In addition, the karyotyping of four subclones (1 : 5, 1 : 8, 1 : 13, 4 : 31) revealed a common form of aneuploidy (69XY).
PCR primers
Below is a list of IGF2-speci®c primers used in this study. Refer to the map in Figure 1 for details of position. p1 5'-CACTCGCACGGGTAGAGAC-3' (exon 1); p2 5'-CGTA-GAGCAACTCGGATTTGG-3' (exon 4); p3 5'-GGACAA TCAGACGAATTCTCC-3' (exon 5); p4 5'-CTTCTCC TGTGAAAGAGACTTC-3' (exon 6); p5 5'-GGTCGTGC CAATTACATTTCA-3' (exon 9; corresponds to primer 2 in Ogawa et al (1993) . p6 5'-CGGGGATGCATAAAG-TATGAG-3' (exon 9); p7 5'-CTTGGACTTTGAGT-CAAATTGG-3' (exon 9; corresponds to primer 3 in Ogawa et al (1993) 
Imprinting assays
The imprinting status of IGF2 was determined by both the direct and indirect (Ogawa et al., 1993) approaches. The H19 imprinting status was determined by RT ± PCR analysis exploiting a polymorphic AluI site within exon 4 (Hashimoto et al., 1995) .
These ampli®cation procedures were quantitative under the conditions used (not shown). Allele-speci®c Southern blot hybridization analysis was performed as has been described (Adam et al., 1996) . Allelic usage was quantitated by analysing the radioactive blot or sequence gen in a Fuji phosphorimager.
Promoter-speci®c IGF2 cDNAs IGF2 speci®c cDNA was made as described previously (EkstroÈ m et al., 1995) . A semi-nested ampli®cation approach was employed to amplify transcripts derived from speci®c promoters. Aliquots of cDNA were used in a 50ml reaction with 4mM primers, 0.25 mM dNTP, 5 U Taqplus DNA polymerase (Stratagene) and 16low salt butter. The ®rst round of ampli®cation was performed using the p6 primer and each of the four exon-speci®c primers (p1,p2,p3 and p4) for 262 min at 958C, 1 min at 508C and 3 min at 728C followed by 30 cycles of 1 min at 948C, 1 min at 558C, 3 min at 728C and 10 min for ®nal extension. The second round of ampli®cation was carried out using 3ml of the ®rst round products as templates and replacing the p6 primer with the p7 primer and repeating the procedure above. The ampli®ed products were phenol/ chloroform-extracted, ethanol precipitated and analysed on a 1% agarose gel. The DNA fragments migrating at the expected position were isolated and puri®ed using Qiaex (Qiagen). Following separation on 1.2% agarose geles, allele-speci®c Southern blot hybridization analysis was performed as has been described (Adam et al., 1996) .
Analysis of IGF2 and H19 expression levels
The relative expression levels of IGF2 and H19 mRNAs were estimated as follows: Ten mg of total cellular RNA was annealed to 32 P-labeled, antisense IGF2 and H19 RNA probes, generated from XhoI-linerised pIGF2 plasmid (SP6 polymerase; (Ohlsson et al., 1989) and DdeI-linearised human H19 cDNA cloned in Bluescript (T7 polymerase; a kind gift of Dr Wolf Reik), and subjected to RNase protection analysis according to manufacturers protocol (Ambion). Followin separation on 8% acrylamide sequencing gels, the signals were visualized by X-ray autoradiography. The expression levels were sometimes related to the mRNA levels of the internal marker GAP (glyceraldehyde 3-phosphate dehydrogenase), by including a 32 P-labeled, antisense GAP RNA probe (pTRI-GAPDH; Ambion) in the probe mix. The promoter usage was analyzed by RNase protection analysis as has been described (EkstroÈ m et al., 1995) . Where indicated, the signals were quantitated by using a Fuji phosphoimager.
